Search databaseBooksAll DatabasesAssemblyBiocollectionsBioProjectBioSampleBioSystemsBooksClinVarConoffered DomainsdbGaPdbVarGeneGenomeGEO DataSetsGEO ProfilesGTRHomoloGeneIdentical Protein Internet CatalogNucleotideOMIMPMCPopSetProteinProtein ClustersProtein Family ModelsPubChem BioAssayPubChem CompoundPubChem SubstancePubMedSNPSRAStructureTaxonomyToolKitToolKitAllToolKitBookgh Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

You are watching: Which of the following does not play a role in blood clotting?

StatPearls . Treasure Island also (FL): StatPearls Publishing; 2021 Jan-.



This post is an analysis of the standard biochemistry involved in the coagulation cascade, particularly clotting components and also their biochemical interactions and roles among cell membranes, platelets, as proteases, and as codeterminants. Other components involved in the procedure of clot formation will be referenced, but the emphasis will be on clotting determinants. The coagulation cascade is a well-studied and pertinent topic that is crucial for wellness professionals to understand. Although this post does not cover the coagulation cascade and its duty in hemostasis as a simple chain of events, a brief overwatch will certainly be had. A thostormy examination of these biochemical interactions will illuminate the underlying intricacies of the coagulation cascade that permit a cohesive process to attribute seamlessly.



Clotting factors are arguably the crux and a lot of essential components of hemostasis. Hemostasis is the body’s physiologic response to vascular endothelial injury, which results in a collection of processes that attempt to retain blood within the vascular mechanism through the development of a clot. Hemostasis deserve to be additionally separated right into major and additional hemostasis. Main hemostasis, which results in the formation of a soft platelet plug, involves vasoconstriction, platelet adhesion, platelet activation, and platelet aggregation. Secondary hemostasis is mainly defined as the formation of fibrinogen into fibrin, which eventually evolves the soft platelet plug into a tough, insoluble fibrin clot. Within major and additional hemostasis, 3 coagulation pathways exist: intrinsic, extrinsic, and also widespread.<1><2><3><4>


The intrinsic pathmeans responds to spontaneous, inner damage of the vascular endothelium whereas the extrinsic pathmethod becomes caused secondary to exterior trauma. Both intrinsic and also extrinsic pathmeans satisfy at a common suggest to continue coagulation, the widespread pathmeans. Clotting factors affiliated in the intrinsic pathmeans encompass components XII, XI, IX, and VIII. Clotting determinants connected in the extrinsic pathmeans encompass determinants VII, and III. The widespread pathmeans has clotting factors X, V, II, I, and also XIII. Clotting factors deserve to also be referred to exterior of their Roman numeral designations. In the intrinsic pathmeans, determinants XII, XI, IX, and also VIII are additionally recognized as Hagemale aspect, plasma thromboplastin antecedent, Christmas factor, and also antihemophilic factor A, respectively. In the extrinsic pathmeans, factors VII and also III are additionally recognized as stabilizing aspect and also tproblem aspect, respectively. The prevalent pathmethod factors X, V, II, I, and XIII are likewise well-known as Stuart-Prower aspect, proaccelerin, prothrombin, fibrinogen, and fibrin-stabilizing factor respectively. Clotting variable IV is a calcium ion that plays a crucial role in all 3 pathways. Some of the clotting determinants feature as serine proteases, specifically determinants II, VI, IX, and also X.


The overwhelming majority of clotting components are made principally in hepatocytes. Hepatocytes are responsible for providing the body through clotting components XIII, XII, XI, X, IX, VII, V, II, and also I. Clotting components VIII (antihemophilic variable A), and III (tworry factor) originate from endothelial cells, whereas clotting aspect IV (calcium ion) is easily obtainable in plasma. Megakaryocytes develop the body’s platelets and additionally add to the production of element V.<5><6>


Vascular injury outcomes in the expocertain of subendothelial collagen and von Willebrand factor (vWF). vWF is a glycoprotein that serves as the initial stationary structure on which a clot develops. Subendothelial vWF, which is also existing in the vasculature and also acts to increase the half-life of XIII, binds to glycoprotein Ib (GpIb) on plateallows. This reasons a conformational readjust on the platelet surchallenge that results in the expocertain of glycoprotein IIb/IIIa (GpIIb/IIIa). Due to the conformational change, circulating fibrinogen attaches to GpIIb/IIIa. At this allude in hemostasis, a soft platelet plug has actually developed, and also the importance of biochemical interactions of clotting determinants arises.

Membrane Binding

In enhancement to the expocertain of GpIIb/IIIa as a result of conformational change occurring on the platelet, phosphatidylserine likewise emerges on the platelet surconfront. Phosphatidylserine is a membrane phospholipid whose polar finish has actually an adverse charge, and, as an outcome, provides an great surface for a calcium ion to bind. The interaction in between negatively charged phosphatidylserine and calcium does not entirely negate calcium’s positive charge. This allows for serine proteases to bind to the surface of the platelet membrane. This binding is possible because of the carboxylation of clotting components II, VII, IX, and also X. These clotting determinants have an area referred to as gamma-carboxyglutamic acid that undergoes vitamin-K dependent carboxylation using gamma-glutamyl carboxylase. The enzyme adds a negatively charged carboxyl group to glutamic acid residues, which calcium easily binds to. As an outcome, the clotting determinants deserve to adhere to the platelet surconfront as serine proteases.

Intrinsic Pathmethod Proteases

Factor XII activation is the initially action of the intrinsic pathmethod. Its activation is induced through call with subendothelial collagen in the existence of high molecular weight kininogen. Graphically, zymogen to enzyme activation was denoted via the letter a, for instance, XIIa. XIIa, subsequently, activates XI into XIa, which leads to the activation of IXa. At this suggest, our previous discussion of gamma-carboxylation and platelet membrane interaction becomes vital. Clotting aspect IX plays its duty as a serine protease within the intrinsic pathway. Although IXa is in its active form, IXa enzyme effectiveness is abysmal without its vital coelement, element XIII. Once XIII and also IXa are bound together (XIII-IXa) on the platelet membrane, proteolysis ensues. Specifically, the serine protease cleaves specific C-terminal arginine residues in the zymogen, which results in its succeeding activation. From below, we can understand also exactly how VIII-IXa activates element X into Xa and also leads into the prevalent pathway.

Extrinsic Pathway Protease

Although the extrinsic pathmeans involves fewer procedures to the common pathmethod, the function of serine proteases is simply as vital. When exterior insult occurs, clotting aspect VII, along with its covariable tworry thromboplastin, becomes an energetic protease and catalyzes X into Xa, which leads into the prevalent pathmethod.


Prothrombin time (PT) steps coagulation throughout the extrinsic pathmethod and prevalent pathmeans. A normal PT time is between 11 to 15 seconds; however, this time may vary slightly in the healthtreatment setting. The worldwide normalized ratio (INR) is used to reduce the slight imbalances in PT, and also additionally is the test of alternative once a patient is on warfarin treatment. A therapeutic INR is generally considered in between 2 to 3 (for a lot of clinical cases requiring anticoagulation through warfarin).<7><8><9>

Partial thromboplastin time (PTT) measures coagulation throughout the intrinsic pathmethod and prevalent pathmeans. A normal PTT time is 25 to 40 seconds. PTT is the test of choice when monitoring a patient on unfractionated heparin. Of note, routine PTT security is not essential for patients on low-molecular-weight heparin.

Bleeding time (BT) is a meacertain of platelet attribute and exactly how well plateallows can create a clot. Regular bleeding time is 2 to 7 minutes. BT time is frequently elevated in conditions of platelet dysfeature.


Here we will talk about frequently tested areas in regard to the pathophysiology of clotting factors.


Hemophilia A is an X-attached recessive coagulopathy that results in dysuseful XIII. From our earlier discussion, we deserve to see just how dyspractical VIII will cause coagulopathy and a prolonged PTT. Patients through this disorder will certainly frequently existing through basic bruising, bleeding after dental actions or from operations in basic, and hemarthrosis. Hemophilia A have the right to be treated through desmopressin and also recombinant factor XIII. Desmopressin causes endothelial cells to release vWF, which stabilizes XIII.

Hemophilia B, sometimes referred to as Christmas illness, is an X-linked recessive coagulopathy that outcomes in dysfeature of IX. Similar to hemophilia A, hemophilia B will certainly likewise reason an extensive PTT. The difference is hemophilia A is a coaspect deficiency while hemophilia B is a protease deficiency; therefore, desmopressin will not be an excellent therapy option as these patients call for recombinant aspect IX. Hemophilia B will certainly existing with the exact same symptoms of hemophilia A. It is vital to note that hemophilia A and B will have actually a normal PT/INR.

Von Willebrand also Disease

vWF disease is the many typically inherited coagulopathy. vWF can be differentiated from hemophilias in several methods. First, vWF mode of inheritance is autosomal leading. Secondly, vWF condition is a condition of platelet dysfunction and will certainly manifest mostly as mucosal membrane bleeding such as epistaxis and expanded menstrual cycles. Thirdly, bleeding time is normal in hemophilias whereas it is expanded in vWF illness. Because vWF increases the half-life of XIII, you can expect to check out an extensive PTT in this disorder as well. Desmopressin can be used as a therapy option; yet, particular subkinds of vWF illness do not warrant this therapy choice. 

Vitamin K Deficiency

Previously, we discussed the prestige of Vitamin K, and its clotting components II, VII, IX, X, protein C and also S. The results of vitamin K deficiency can be oboffered in both the extrinsic and also intrinsic pathways and directly measured using PT and PTT, which will be expanded. The etiology of vitamin K deficiency is extensive yet generally arises on test questions in regards to patients with bad diet, pancreatic insufficiency, liver illness, intestinal flora inequalities, neonates, or mimicked by patients on warfarin therapy.


Vitamin K assists in the carboxylation of clotting components II, VII, IX, X, protein C and S. The enzyme responsible for gamma-carboxylation is vitamin K epoxide reductase, which is inhibited by warfarin. As stated previously, patients on warfarin will certainly have the coagulation condition measured via INR. In emergency clinical settings, warfarin’s therapeutic impacts are negated by the management of fresh frozen plasma. In a much less immediate clinical establishing, patients may be administered vitamin K. Rarely; patients might suffer warfarin-induced skin necrosis within the initially few days of beginning warfarin. This is as a result of protein C having actually the shortest half-life of vitamin K dependent clotting determinants, and therefore a patient enters a prothrombotic state. However, this rare complication is more prevalent in patients through protein C deficiency. To help get rid of this complication, patients are often co-administered heparin while beginning warfarin treatment as heparin’s oncollection is prompt while warfarin’s onset takes 2 to 3 days.

See more: Como Depositar Dinero A Un Detenido Por Ice Processing Center

Clinical Significance

By knowledge the biochemistry of clotting components, healthcare specialists have the right to conveniently identify probable causes of a patient"s coagulopathy by examining a patient"s coagulation studies. For elevations in PT/INR, we have the right to focus in on problems such as liver disease, warfarin usage, vitamin-K deficiency, and deficiencies in the extrinsic or common pathmeans. For elevations in PTT, we narrowhead our emphasis on more widespread causes such as hemophilias, unfractionated heparin usage, vitamin-K deficiency, and also vWF, through mindful attention to BT. It is vital to remember that prolongations in PT and also PTT might additionally be because of deficiencies in the common pathmethod, however the previous problems and examples yield a higher probability of identifying the root of the coagulopathy.<1><10>